EUVIMEDEUVIMED entdecken
Open Access

De novo CLPTM1 variants with reduced GABA A R current response in patients with epilepsy

Nana Liu iD, Jinliang Li, Kai Gao, Riley E Perszyk, Jing Zhang, Jingmin Wang, Ye Wu, Andrew Jenkins, Hongjie Yuan, Stephen F Traynelis, Yuwu Jiang iD

Epilepsia · 2023

DOI: 10.1111/epi.17746 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, 2023. Verfasst von Nana Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: Receptors, GABA-A, Epilepsy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, Natural Science Foundation of Beijing Municipality, China Scholarship Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate the clinical features and potential pathogenesis mechanism of de novo CLPTM1 variants associated with epilepsy.

Methods

Identify de novo genetic variants associated with epilepsy by reanalyzing trio‐based whole‐exome sequencing data. We analyzed the clinical characteristics of patients with these variants and performed functional in vitro studies in cells expressing mutant complementary DNA for these variants using whole‐cell voltage‐clamp current recordings and outside‐out patch‐clamp recordings from transiently transfected human embryonic kidney (HEK) cells.

Results

Two de novo missense variants related to epilepsy were identified in the CLPTM1 gene. Functional studies indicated that CLPTM1 ‐p.R454H and CLPTM1 ‐p.R568Q variants reduced the γ‐aminobutyric acid A receptor (GABA A R) current response amplitude recorded under voltage clamp compared to the wild‐type receptors. These variants also reduced the charge transfer and altered the time course of desensitization and deactivation following rapid removal of GABA. The surface expression of the GABA A R γ2 subunit from the CLPTM1 ‐p.R568Q group was significantly reduced compared to CLPTM1 ‐WT. Significance This is the first report of functionally relevant variants within the CLPTM1 gene. Patch‐clamp recordings showed that these de novo CLPTM1 variants reduce GABA A R currents and charge transfer, which should promote excitation and hypersynchronous activity. This study may provide insights into the molecular mechanisms of the CLPTM1 variants underlying the patients’ phenotypes, as well as for exploring potential therapeutic targets for epilepsy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, GABA-AEpilepsyHumansMutation, MissensePhenotypegamma-Aminobutyric AcidMembrane Proteins

Stichwörter der Autor:innen

channelopathyepilepsyloss-of-functiontranslational studytrio-based whole-exome sequencing

Substanzen

Receptors, GABA-Agamma-Aminobutyric AcidCLPTM1 protein, humanMembrane Proteins

Autor:innen und Institutionen

  • Department of Pediatrics, Peking University First Hospital, Beijing, China.
  • Beijing Key Laboratory of Molecular Diagnosis and Study on Pediatric Genetic Diseases, Beijing, China.
  • Children Epilepsy Center, Peking University First Hospital, Beijing, China.
  • Department of Pediatrics, Central People's Hospital of Zhanjiang, Guangdong, China.
  • Key Laboratory for Neuroscience, Ministry of Education/National Health and Family Planning Commission, Peking University, Beijing, China.
  • Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, Georgia, USA.

ORCID-Profile: Nana Liu, Yuwu Jiang

Förderung

  • NINDS NIH HHS
  • Natural Science Foundation of Beijing Municipality
  • China Scholarship Council
  • Fundamental Research Funds for the Central Universities
  • National Institute of Neurological Disorders and Stroke
  • National Basic Research Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Liu, N., Li, J., Gao, K., Perszyk, R. E., Zhang, J., Wang, J., Wu, Y., Jenkins, A., Yuan, H., Traynelis, S. F., & Jiang, Y. (2023). De novo CLPTM1 variants with reduced GABA A R current response in patients with epilepsy. Epilepsia. https://doi.org/10.1111/epi.17746

Vancouver

Liu N, Li J, Gao K, Perszyk RE, Zhang J, Wang J, et al. De novo CLPTM1 variants with reduced GABA A R current response in patients with epilepsy. Epilepsia. 2023. doi:10.1111/epi.17746

BibTeX
@article{Liu2023,
  author = {Liu, Nana and Li, Jinliang and Gao, Kai and Perszyk, Riley E and Zhang, Jing and Wang, Jingmin and Wu, Ye and Jenkins, Andrew and Yuan, Hongjie and Traynelis, Stephen F and Jiang, Yuwu},
  title = {De novo CLPTM1 variants with reduced GABA A R current response in patients with epilepsy},
  journal = {Epilepsia},
  year = {2023},
  doi = {10.1111/epi.17746}
}
Kostenlos starten →